CEO, Molecular Partners

Executive Editor, Endpoints

Senior Reporter, ApexOnco

President & CEO at Bellus Health

Director of Visibility and External Communications, BeiGene

Executive Chairperson, EQRX

Former President, Novartis Institutes for BioMedical Research

Senior Editor, Endpoints

President & CEO, MiNK Therapeutics

Editor, Biotech Strategy Blog

Co-CEO and Co-Founder, Amylyx Pharmaceuticals

CEO, Corbus Pharmaceuticals

Executive Editor and Head of Daily Global Intelligence, BioCentury

President and CEO of the Biotechnology Innovation Organization

Founder & Managing Director Pharmagellan; Tufts Professor and Author

Reporter, STAT

CEO, Codexis

Chief Innovation and Strategy Officer, PureTech Health; Inventor of KarXT Platform & Founding CEO, Karuna Therapeutics

CEO, Beam Therapeutics

Managing Director and Senior Biotech Analyst, Needham & Co.

Senior pharmaceuticals analyst for Bloomberg Intelligence and director of research for EMEA.

Senior Writer, STAT

Editor in Chief, BioCentury

National Biotech Reporter, STAT

Chief Executive Officer, Arrakis Therapeutics

CEO, Roivant

Chief Innovation Officer, Centessa

Director of the Medical Oncology Service, National Cancer Institute

SVP, Remix Therapeutics

Chief Investment Officer, Metagenomi

CEO, Nkarta

CMO, Arcellx

CEO, Immunocore

Pharma Columnist, Bloomberg Opinion

CEO, DICE Therapeutics

Associate Professor of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School; Founder, Foghorn Therapeutics

Portfolio manager in the equity division at Fidelity Investments

CEO, Nimbus Therapeutics

Co-Founder and CEO, Ginkgo Bioworks

Co-CEO and Co-Founder, Amylyx Pharmaceuticals

Executive Editor, BioCentury

Managing Partner, RA Capital Management

Co-founder, Chief Executive Officer and member of Board of Directors, BridgeBio

Partner in New York Office of Bessemer Venture Partners

Professor in Cancer Gene Therapy, University of Pennsylvania

President & CEO, Valneva

Director in Chemical Biology Therapeutics, Novartis Institutes for BioMedical Research (NIBR)

Former Executive Vice President of Pharmaceuticals, R&D, Johnson & Johnson

Former CEO of Alnylam

Founder and COO, Inventor of KarXT Platform, Karuna Therapeutics

CEO, EQRX

Co-founder and Managing Director, ARCH Venture Partners

Managing director, SVB's Healthcare practice

CEO, bluebird bio

Founder Semma (acquired by Vertex Pharmaceuticals)

Researcher, UCSF Neurologic Oncology

Founder and CEO, Perlara PBC; Co-Founder and CEO, Maggie's Pearl

Journalist, ApexOnco

President of Research & Development, Takeda

CEO, Nuvalent

Senior Manager Director, Evercore ISI

Senior Editor for Biomedicine, MIT Technology Review

CEO, President and CSO, Aleta Biotherapeutics

EVP, Strategy, Nucleate

Life Sciences Portfolio Manager

Biotech Analyst, Cantor

Biopharma writer, Nature Biotechnology and In Vivo

CEO, Kite Pharma

Chief Advocacy Officer, BIO

CEO, Immatics

Senior Research Analyst, Baird

President and CEO, Trillium Therapeutics

Executive Director, Incubate Coalition

Managing Director, Mizuho Securities

Founder, Timmerman Report

CEO Morphic Therapeutic

Partner and a Founding Member of the Healthcare Practice, Centerview Partners

Scientific Director, Innovative Genomics Institute; Professor, MCB Department, UC Berkeley; Scientific co-founder, Tune Therapeutics

Washington Editor, BioCentury

Managing Editor, Enterprise, MarketWatch and author of For Blood and Money: Billionaires, Biotech, and the Quest for a Blockbuster Drug

CEO, Portage Bio

Senior Biotechnology Analyst, TD Cowen